Form 15-12G ABRAXAS PETROLEUM CORP
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-16071
ABRAXAS PETROLEUM CORPORATION
(Exact name of registrant as specified in its charter)
18803 Meisner Drive
San Antonio, Texas 78258
(210) 490-4788
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) |
☒ | |
Rule 12g-4(a)(2) |
☐ | |
Rule 12h-3(b)(1)(i) |
☐ | |
Rule 12h-3(b)(1)(ii) |
☐ | |
Rule 15d-6 |
☒ | |
Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice date: 184
Pursuant to the requirements of the Securities Exchange Act of 1934 Abraxas Petroleum Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
ABRAXAS PETROLEUM CORPORATION | ||||||
Date: February 1, 2023 | By: | /s/ Robert L.G. Watson | ||||
Robert L.G. Watson | ||||||
President and Chief Executive Officer |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
- Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
- Transaction in Own Shares
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!